United States Pharmacopeia
Compendial standards body; its General Chapters carry the force of law under the FD&C Act.
WHAT USP COVERS
The United States Pharmacopeia is a non-governmental standards-setting organisation that publishes the USP–NF, containing monographs for drug substances, products, excipients, and dietary supplements, together with general chapters describing tests and practices.
WHERE IT SITS INTERNATIONALLY
USP participates in the Pharmacopoeial Discussion Group with the European and Japanese pharmacopoeias, which has harmonised a subset of general chapters and excipient monographs — but only a subset.
HOW ITS REQUIREMENTS BITE
USP does not inspect, but its standards are enforceable in the US: under the FD&C Act a drug recognised in the compendium that fails to conform to its monograph standards may be deemed adulterated or misbranded. The distinction between general chapters matters — those numbered below <1000> are potentially enforceable requirements, while those numbered <1000> and above are informational.
WHAT USP PUBLISHES
- 01USP–NF monographs for substances, products, excipients, and supplements
- 02General chapters below <1000> — enforceable, e.g. <71> sterility, <85> bacterial endotoxins, <61>/<62> microbial enumeration
- 03General chapters <1000> and above — informational, e.g. <1116> aseptic environments, <1117> microbiological best practices
- 04Reference standards used to calibrate and validate analytical methods
- 05Pending revisions through Pharmacopeial Forum for public comment
WHAT PRACTITIONERS GET WRONG
- ›The <1000> boundary is the single most useful thing to know: below is enforceable, above is guidance.
- ›USP, Ph. Eur., and JP monographs are harmonised only in part — never assume equivalence without checking.
- ›Monographs are living documents; verify you are working from the current official version.
- ›Compendial compliance is a floor, not a ceiling — your specification may need to be tighter.
USP STANDARDS SPEQ DECODES · 7
DISCIPLINES IN USP’S REMIT
Track USP — and every regulator that matters
New rules, guidance, enforcement, and inspection signals from United States Pharmacopeia and its peers worldwide, distilled into the free Weekly GxP Briefing.